微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -3.73% | -148.89% | -18.79% | 44/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -3.14% | -147.29% | -90.3% | 45/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -1.65% | -133.47% | -138.55% | 43/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 4.28% | -89.24% | -43.91% | 26/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 7.63% | -77.11% | 14.91% | 17/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 6.64% | -75.14% | 34.69% | 14/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 4.93% | -46.06% | -87.6% | 6/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 39.77% | 191.57% | 19.32% | 1/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 33.33% | 214.14% | 24.78% | 4/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 26.71% | 349.66% | 192.23% | 3/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 9.14% | 255.64% | -32.99% | 5/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 13.64% | 52.23% | 28.56% | 20/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 10.61% | 40.34% | 78.62% | 20/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 5.94% | 55.91% | 131.13% | 23/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 2.57% | 64.74% | -71.32% | 17/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 8.96% | 64.1% | 18.52% | 31/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 7.56% | 63.64% | 98.43% | 17/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 3.81% | 91.46% | 144.23% | 20/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 1.56% | 178.57% | -71.43% | 11/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 5.46% | 62.99% | 18.18% | 34/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 4.62% | -9.77% | 132.16% | 20/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 1.99% | 55.47% | 255.36% | 22/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 0.56% | -64.78% | -83.28% | 21/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 3.35% | -50.74% | -34.57% | 33/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 5.12% | -5.88% | 300% | 16/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 1.28% | -71.11% | -19.5% | 26/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.59% | -63.02% | -76.62% | 12/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 6.8% | -53.14% | 25% | 22/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 5.44% | -47.49% | 22.8% | 17/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 4.43% | -46.43% | 3.02% | 14/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 4.3% | 7.77% | -70.37% | 5/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 14.51% | 24.34% | 40.06% | 14/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 10.36% | 13.97% | 25.27% | 6/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 8.27% | 26.65% | 107.27% | 8/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 3.99% | 6.12% | -65.81% | 4/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 11.67% | -29.49% | 28.38% | 13/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 9.09% | -2.15% | 39.2% | 8/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 6.53% | 7.4% | 73.67% | 5/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 3.76% | -42.77% | -77.28% | 6/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |